Rights Issue10 Jul 2026, 05:51 pm
Natural Biogenex Approves Rights Issue of ₹1.11 Cr
AI Summary
Natural Capsules Ltd's material unlisted subsidiary, Natural Biogenex Private Limited, has approved a Rights Issue. The issue involves 11,16,766 equity shares of Rs. 10 each, offered at par, for a total aggregate amount of Rs. 1,11,67,660 (approximately ₹1.11 Crore). This corporate action aims to raise capital for the subsidiary.
Key Highlights
- Subsidiary Natural Biogenex approves Rights Issue.
- Issue size is 11,16,766 equity shares at Rs. 10 each.
- Total funds to be raised amount to ₹1.11 Crore.
- This is a capital raising initiative by the unlisted subsidiary.
Price Impact
More from NATCAPSUQ